Chan, A., Conte, P., Petruzelka, L., Tubiana-Mathieu, N., Ganju, V., Llombart, A., . . . Villanova, G. (2013). Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer.
Chicago Style (17th ed.) CitationChan, Arlene, et al. Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer. 2013.
MLA (9th ed.) CitationChan, Arlene, et al. Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer. 2013.
Warning: These citations may not always be 100% accurate.